All Stories

  1. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Dr J. M. Schattenberg

  2. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Dr J. M. Schattenberg

  3. The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm

    Article • Hepatology, July 2017, Wiley

    Dr J. M. Schattenberg

  4. Ätiologie und Komplikationen der Leberzirrhose: Daten eines deutschen Zentrums

    Article • DMW - Deutsche Medizinische Wochenschrift, August 2014, Thieme Publishing Group

    Dr J. M. Schattenberg, PD Dr. Arndt Weinmann

  5. Medikamentöse Schädigung der Leber mit autoimmunem Phänotyp durch TNF-Blockade – Fallvorstellung und Review der Literatur

    Article • Seminars in Musculoskeletal Radiology, January 2014, Thieme Publishing Group

    Dr J. M. Schattenberg